Navigation Links
Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
Date:2/24/2009

ALISO VIEJO, Calif., Feb. 24 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced fourth quarter and full year financial results for 2008.

"With our new strategic initiatives beginning to take hold in the fourth quarter, we continue to make strides in staging Valeant for sustainable future growth," said J. Michael Pearson, chairman and chief executive officer. "We added to our future revenue and cash flow potential by acquiring three solid dermatology businesses, while we continue to see the impact of our cost reduction efforts. We exceeded our goal of $0.60 - $0.80 cash earnings per share for 2008 and expect this solid progress to continue into 2009."

New Segment Information:

We restructured our organization in the fourth quarter of 2008 in order to improve our execution and align our resources and product development efforts in the markets in which we operate. Our products are sold through three new segments comprising of Specialty Pharmaceuticals, Branded Generic - Europe and Branded Generic - Latin America. The Specialty Pharmaceuticals segment includes product revenues primarily from the U.S., Canada, Australia and divested businesses located in Argentina, Uruguay and Asia. The Branded Generic - Europe segment includes product revenues from branded generic pharmaceutical products primarily in Poland, Hungary, the Czech Republic and Slovakia. The Branded Generic - Latin America segment includes product revenues from branded generic pharmaceutical products primarily in Mexico and Brazil.

Revenues:

Total revenue was $183.0 million in the fourth quarter of 2008 as compared to $188.9 million in the fourth quarter of 2007.

Specialty Pharmaceutical product sales were $89.2 million in the fourth quarter of 2008, as co
'/>"/>

SOURCE Valeant Pharmaceuticals International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
2. Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
10. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Santa Clara, CA (PRWEB) March 06, 2015 ... Bryan tickets at Levi's® Stadium in Santa Clara, California. ... it has already hosted a plethora of exciting events. , ... Bryan will bring his popular summer tour to the west ... of the art facility will take place on August 29 ...
(Date:3/6/2015)... Jose, California (PRWEB) March 06, 2015 ... also known as the pharmacokinetics of a drug refers ... a pharmaceutical compound inside an organism. When toxicity studies ... ADME-Tox or ADMET or ADME/Tox. Increasing focus on lowering ... adoption of ADME-toxicology testing worldwide. The traditional drug development ...
(Date:3/6/2015)... 06, 2015 Parents need to start ... of substance use disorders. School programs like DARE, or ... successful. NOPE, or Narcotics Overdose Prevention and Education has ... Healthline News on Feb. 27th. As teens ... opiate drugs, drug prevention proponents are lobbying Florida to ...
(Date:3/6/2015)... California (PRWEB) March 06, 2015 Johnson ... million jury verdict on March 5, 2015 in Superior ... According to court documents, a jury of 12 awarded ... suffered from being implanted with an Ethicon TVT Abbrevo ... nine men and three women also awarded $5 million ...
(Date:3/6/2015)... DC (PRWEB) March 06, 2015 Magellan ... nation’s only comprehensive source for key trends and statistics ... spend, medical injectables. Executives from Magellan Rx Management will ... Trend Report: Discover Your Hidden Specialty Drug Spend,” a ... Information Services, Inc. , Specialty drug spend makes up ...
Breaking Medicine News(10 mins):Health News:Cheap Luke Bryan Tickets at Levi's® Stadium in Santa Clara, CA: Ticket Down Slashes Ticket Prices on Luke Bryan Concert Tickets in Santa Clara at the New Levi's® Stadium 2Health News:Cheap Luke Bryan Tickets at Levi's® Stadium in Santa Clara, CA: Ticket Down Slashes Ticket Prices on Luke Bryan Concert Tickets in Santa Clara at the New Levi's® Stadium 3Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2
... - 20% U.S. Sequential Quarterly Sales Increase - ... - FY08 Revenue Projection Raised - ... - Conference Call to be Held at 10:00 a.m. Central Time Today -, ... for the second quarter,of fiscal 2008 ended September 30, 2007, up 73% from $1.8 million ...
... Adults Reap Significant Benefits in Less than a ... American Council on Exercise,(ACE), your premier certification, education ... study that examined functional,fitness programming for older adults; ... world benefits relatively quickly. With the goal of ...
... parameters published in the November 1 issue of the ... and treatment of circadian rhythm sleep disorders (CRSDs). ... behavior, patient outcomes and possibly health care costs. , ... practice parameters, commissioned content experts in CRSDs to review ...
... BERKELEY, Calif., Nov. 1 Dynavax Technologies,Corporation (Nasdaq: ... the third,quarter and nine months ended September 30, ... of today,s arrangement with Merck. As of ... securities and investments held by Symphony Dynamo, Inc. ...
... LONDON, Nov. 1 Chiltern, a leading global clinical,research organization ... at,the Annual Partnerships in Clinical Trials Conference; which will be ... Exhibit and,Congress Center. Chiltern will sponsor "welcome coffee breaks" from ... 9:00 am on Nov. 7th. Chiltern will,also be present at ...
... time when the U.S. spends more than double what other ... Commonwealth Fund seven-nation survey finds that U.S. patients are more ... because of costs, and to say that the health care ... with Canadians, are also the least likely to be able ...
Cached Medicine News:Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 2Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 3Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 4Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 5Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 6Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 7Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 8Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 9Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 10Health News:Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter 11Health News:Exclusive American Council on Exercise (ACE) Research Study Proves Functional Fitness Really Works 2Health News:Practice parameters discuss the evaluation, treatment of circadian rhythm sleep disorders 2Health News:Practice parameters discuss the evaluation, treatment of circadian rhythm sleep disorders 3Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 2Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 3Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 4Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 5Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 6Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 7Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 8Health News:Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook 9Health News:Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam 2Health News:US adults most likely to report medical errors and skip needed care due to costs 2Health News:US adults most likely to report medical errors and skip needed care due to costs 3Health News:US adults most likely to report medical errors and skip needed care due to costs 4
(Date:3/6/2015)... , March 6, 2015  Pomerantz LLP is ... Inc. ("Conatus" or the "Company") (NASDAQ: CNAT ... S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ... and certain of its officers and/or directors have violated ... of 1934.  On March 5, 2015, ...
(Date:3/6/2015)... , March 6, 2015   Prime Therapeutics ... more than 26 million members, today released the following ... (FDA) approval of the first biosimilar to enter the ... Drug Administration (FDA) approval of Sandoz,s Zarxio® to treat ... patients, is a major milestone in our country,s journey ...
(Date:3/6/2015)... DALLAS , March 6, 2015  Ascendant Solutions, ... the "Company") today announced its results for the fourth ... reported consolidated net income of $105,000, or less than ... quarter ended December 31, 2014.  This compares with net ... of $6,551,000 for the fourth quarter of 2013. The ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Conatus Pharmaceuticals Inc. - CNAT 2Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed 2Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed 3Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 2Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 3Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 4Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 5
... AUSTIN, Texas, Dec. 12, 2011  There is new hope for ... as "foot drop" due to cerebral palsy (CP).  At ... Cerebral Palsy Developmental Medicine on Saturday, October 15, researchers ... study that shows the WalkAide System successfully improves mobility ...
... Dec. 12, 2011 Reportlinker.com announces that ... in its catalogue: Global ... http://www.reportlinker.com/p0703211/Global-Hospital-Information-Systems-HIS-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=e-Healthc This ... Information Systems (HIS) in US$ Millions by ...
Cached Medicine Technology:NIH Study Shows WalkAide Device by Hanger Orthopedic Group Significantly Improves Walking Ability In Children With Cerebral Palsy 2NIH Study Shows WalkAide Device by Hanger Orthopedic Group Significantly Improves Walking Ability In Children With Cerebral Palsy 3NIH Study Shows WalkAide Device by Hanger Orthopedic Group Significantly Improves Walking Ability In Children With Cerebral Palsy 4Global Hospital Information Systems (HIS) Industry 2Global Hospital Information Systems (HIS) Industry 3Global Hospital Information Systems (HIS) Industry 4Global Hospital Information Systems (HIS) Industry 5Global Hospital Information Systems (HIS) Industry 6Global Hospital Information Systems (HIS) Industry 7Global Hospital Information Systems (HIS) Industry 8Global Hospital Information Systems (HIS) Industry 9Global Hospital Information Systems (HIS) Industry 10Global Hospital Information Systems (HIS) Industry 11Global Hospital Information Systems (HIS) Industry 12Global Hospital Information Systems (HIS) Industry 13Global Hospital Information Systems (HIS) Industry 14Global Hospital Information Systems (HIS) Industry 15Global Hospital Information Systems (HIS) Industry 16Global Hospital Information Systems (HIS) Industry 17Global Hospital Information Systems (HIS) Industry 18Global Hospital Information Systems (HIS) Industry 19Global Hospital Information Systems (HIS) Industry 20Global Hospital Information Systems (HIS) Industry 21Global Hospital Information Systems (HIS) Industry 22
Inquire...
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
... Aerosol barrier tips eliminate false signals ... designed and tested, Promega Barrier Tips ... with amplified nucleic acids (PCR(a)), radioactive ... forensic and serological specimens. , ,Promega ...
Medicine Products: